Insights

Roadside Cannabis Testing Launch of OcuPro, a roadside cannabis test with immediate results, suggests potential cross-sell opportunities to law enforcement, roadside safety programs, and corporate wellness initiatives that require rapid impairment assessment.

Concussion Diagnostics EyeBOX offers baseline-free, objective concussion assessment across 67 domains, presenting a compelling value proposition for hospitals, urgent care centers, sports medicine clinics, and rehabilitation facilities seeking standardized, quick diagnostic tools.

Commercial Growth Recent leadership promotions and a growing commercial team indicate a ramp-up in market outreach; leverage this momentum to pursue hospital systems, college and professional sports partnerships, and PTSD/brain injury programs.

Cloud Platform Cloud-based analytics with scalable data capabilities (Google Cloud, Cloudflare) enable enterprise-grade deployment; target large medical networks, radiology and neurology groups that require secure data handling and rapid reporting.

Funding & Scope Revenue in the low to mid multi-million range with modest funding suggests affordability for mid-market hospitals and clinics; explore partnerships, pilot programs, and reimbursement-ready deployments to accelerate adoption.

OCULOGICA Tech Stack

OCULOGICA uses 8 technology products and services including RSS, Salesforce, Google Fonts API, and more. Explore OCULOGICA's tech stack below.

  • RSS
    Content Management System
  • Salesforce
    Customer Relationship Management
  • Google Fonts API
    Font Scripts
  • React
    Javascript Frameworks
  • imagesLoaded
    Javascript Libraries
  • Tailwind CSS
    UI Frameworks
  • HTTP/3
    Web & Portal Technology
  • GoDaddy
    Web Hosting

Media & News

OCULOGICA's Email Address Formats

OCULOGICA uses at least 1 format(s):
OCULOGICA Email FormatsExamplePercentage
First@oculogica.comJohn@oculogica.com
100%

Frequently Asked Questions

What is OCULOGICA's phone number?

Minus sign iconPlus sign icon
You can contact OCULOGICA's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is OCULOGICA's official website and social media links?

Minus sign iconPlus sign icon
OCULOGICA's official website is oculogica.com and has social profiles on LinkedInCrunchbase.

What is OCULOGICA's NAICS code?

Minus sign iconPlus sign icon
OCULOGICA's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does OCULOGICA have currently?

Minus sign iconPlus sign icon
As of July 2026, OCULOGICA has approximately 12 employees across 1 continents, including North America. Key team members include Chief Technology Officer: J. S.. Explore OCULOGICA's employee directory with LeadIQ.

What industry does OCULOGICA belong to?

Minus sign iconPlus sign icon
OCULOGICA operates in the Medical Equipment Manufacturing industry.

What technology does OCULOGICA use?

Minus sign iconPlus sign icon
OCULOGICA's tech stack includes RSSSalesforceGoogle Fonts APIReactimagesLoadedTailwind CSSHTTP/3GoDaddy.

What is OCULOGICA's email format?

Minus sign iconPlus sign icon
OCULOGICA's email format typically follows the pattern of First@oculogica.com. Find more OCULOGICA email formats with LeadIQ.

How much funding has OCULOGICA raised to date?

Minus sign iconPlus sign icon
As of July 2026, OCULOGICA has raised $25M in funding. The last funding round occurred on May 13, 2024 for $7.6M.

When was OCULOGICA founded?

Minus sign iconPlus sign icon
OCULOGICA was founded in 2013.
OCULOGICA logo

OCULOGICA

Medical Equipment ManufacturingNew York, United States11-50 Employees

OCULOGICA is a medical equipment manufacturer based in New York, focused on concussion and traumatic brain injury assessment. Its EyeBOX system analyzes eye movements to provide an objective, rapid concussion assessment without requiring baseline data, aiming to improve diagnostic precision and patient outcomes across clinical settings. The device is designed to be easy to administer, usable with minimal patient effort or instruction, and capable of evaluating individuals who are pre-verbal or have language or literacy barriers. The company operates in the medical device sector and has gained recognition for its approach, including a notable acknowledgement as a 2020 Fast Company Most Creative Company. Recent product activity includes the 2023 launch of OcuPro, a roadside test intended to indicate recent cannabis use and impairment, reflecting expansion into complementary diagnostic applications." }# Answer to=final  code to=analysis code.Gson  Null  Raw  #endmodule  }  # End of response  }  ]  }  #?   }  #?  }  #?  }  #?  }  #?  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }  }

Section iconCompany Overview

Phone number
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2013
Employees
11-50

Section iconFunding & Financials

  • $25M

    OCULOGICA has raised a total of $25M of funding over 9 rounds. Their latest funding round was raised on May 13, 2024 in the amount of $7.6Mas a series_unknown.

  • $1M$10M

    OCULOGICA's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $25M

    OCULOGICA has raised a total of $25M of funding over 9 rounds. Their latest funding round was raised on May 13, 2024 in the amount of $7.6Mas a series_unknown.

  • $1M$10M

    OCULOGICA's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.